Allos Therapeutics Inc Watch

from 8-K 49 pages Allos Therapeutics, Inc. (A Delaware Corporation) 14,000,000 Shares of Common Stock Purchase Agreement

from 8-K 44 pages Allos Therapeutics, Inc. (A Delaware Corporation) 7,750,000 Shares of Common Stock Purchase Agreement

from 8-K 46 pages Allos Therapeutics, Inc. (A Delaware Corporation) 10,800,000 Shares of Common Stock Purchase Agreement

from 8-K 45 pages Allos Therapeutics, Inc. (A Delaware Corporation) 9,000,000 Shares of Common Stock Purchase Agreement

from SC 13D 1 page <page> Exhibit 1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on Schedule 13d Filed by the Undersigned With Respect to the Common Stock and Exchangeable Preferred Stock of the Allos Therapeutics, Inc. Is, and Any Amendment Thereto Signed by Each of the Undersigned Shall Be, Filed on Behalf of Each Undersigned Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. Dated: March 7, 2005 Warburg Pincus Private Equity VIII, L.P. By: Warburg Pincus & Co., General Partner By: /S/ Scott A. Arenare Name: Scott A. Arenare Title: Partner Dated: March 7, 2005 Warburg Pincus & Co. By: /S/ Scott A. Arenare Name: Scott A. Arenare Title: Partner Dated: March 7, 2005 Warburg Pincus LLC By: /S/ Scott A. Arenare Name: Scott A. Arenare Title: Managing Director

from 8-K 11 pages Confidential Michael E. Hart President and Chief Executive Officer Allos Therapeutics, Inc. 11080 Circlepoint Road Suite 200 Westminster, Colorado 80020 Dear Michael

from S-1/A ~50 pages Form of Underwriting Agreement

from S-1 1 page Form of Lock-Up Agreement

from S-1 ~20 pages Preliminary Form of Underwriting Agreement